Modeling the Slow CD4+ T Cell Decline in HIV-Infected Individuals

The progressive loss of CD4+ T cell population is the hallmark of HIV-1 infection but the mechanism underlying the slow T cell decline remains unclear. Some recent studies suggested that pyroptosis, a form of programmed cell death triggered during abortive HIV infection, is associated with the release of inflammatory cytokines, which can attract more CD4+ T cells to be infected. In this paper, we developed mathematical models to study whether this mechanism can explain the time scale of CD4+ T cell decline during HIV infection. Simulations of the models showed that cytokine induced T cell movement can explain the very slow decline of CD4+ T cells within untreated patients. The long-term CD4+ T cell dynamics predicted by the models were shown to be consistent with available data from patients in Rio de Janeiro, Brazil. Highly active antiretroviral therapy has the potential to restore the CD4+ T cell population but CD4+ response depends on the effectiveness of the therapy, when the therapy is initiated, and whether there are drug sanctuary sites. The model also showed that chronic inflammation induced by pyroptosis may facilitate persistence of the HIV latent reservoir by promoting homeostatic proliferation of memory CD4+ cells. These results improve our understanding of the long-term T cell dynamics in HIV-1 infection, and support that new treatment strategies, such as the use of caspase-1 inhibitors that inhibit pyroptosis, may maintain the CD4+ T cell population and reduce the latent reservoir size.

[1]  Richard A. Lempicki,et al.  Identification of Dynamically Distinct Subpopulations of T Lymphocytes That Are Differentially Affected by HIV , 2001, The Journal of experimental medicine.

[2]  Alan S. Perelson,et al.  A Novel Antiviral Intervention Results in More Accurate Assessment of Human Immunodeficiency Virus Type 1 Replication Dynamics and T-Cell Decay In Vivo , 2003, Journal of Virology.

[3]  A. Aderem,et al.  Caspase‐1‐induced pyroptotic cell death , 2011, Immunological reviews.

[4]  G Janossy,et al.  The importance of lymphocyte trafficking in regulating blood lymphocyte levels during HIV and SIV infections. , 1999, Seminars in immunology.

[5]  Libin Rong,et al.  Asymmetric division of activated latently infected cells may explain the decay kinetics of the HIV-1 latent reservoir and intermittent viral blips. , 2009, Mathematical biosciences.

[6]  S. Twu,et al.  Life expectancy of patients with newly-diagnosed HIV infection in the era of highly active antiretroviral therapy. , 2006, QJM : monthly journal of the Association of Physicians.

[7]  J. French,et al.  Interleukin-1β Biosynthesis Inhibition Reduces Acute Seizures and Drug Resistant Chronic Epileptic Activity in Mice , 2011, Neurotherapeutics.

[8]  F. Lafeber,et al.  Interleukin-7: a key mediator in T cell-driven autoimmunity, inflammation, and tissue destruction. , 2012, Current pharmaceutical design.

[9]  A. Jadhav,et al.  A Highly Potent and Selective Caspase 1 Inhibitor that Utilizes a Key 3‐Cyanopropanoic Acid Moiety , 2010, ChemMedChem.

[10]  Steven G. Deeks,et al.  Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans , 1999, Nature Medicine.

[11]  A. Perelson,et al.  Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection , 1995, Nature.

[12]  R. Koup,et al.  Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia. , 2003, Immunity.

[13]  Eric J Kunkel,et al.  Chemokines and the tissue-specific migration of lymphocytes. , 2002, Immunity.

[14]  N. Ford,et al.  Life Expectancy of Persons Receiving Combination Antiretroviral Therapy in Low-Income Countries: A Cohort Analysis From Uganda , 2011, Annals of Internal Medicine.

[15]  I. Kushner,et al.  Acute-phase proteins and other systemic responses to inflammation. , 1999, The New England journal of medicine.

[16]  C. Struchiner,et al.  Viral Load and CD4 Count Dynamics After HIV-1 Seroconversion in Homosexual and Bisexual Men in Rio de Janeiro, Brazil , 2006, Journal of acquired immune deficiency syndromes.

[17]  Alan S. Perelson,et al.  Determination of virus burst size in vivo using a single-cycle SIV in rhesus macaques , 2007, Proceedings of the National Academy of Sciences.

[18]  H. Ullum,et al.  Persistent Inflammation and Endothelial Activation in HIV-1 Infected Patients after 12 Years of Antiretroviral Therapy , 2013, PloS one.

[19]  Steve Kaye,et al.  Short-course antiretroviral therapy in primary HIV infection. , 2013, The New England journal of medicine.

[20]  L M Wahl,et al.  Viral dynamics of primary viremia and antiretroviral therapy in simian immunodeficiency virus infection , 1997, Journal of virology.

[21]  L. Rong,et al.  Stochastic population switch may explain the latent reservoir stability and intermittent viral blips in HIV patients on suppressive therapy. , 2014, Journal of theoretical biology.

[22]  D. Mooney,et al.  Transcriptional profiling of stroma from inflamed and resting lymph nodes defines immunological hallmarks , 2012, Nature Immunology.

[23]  L. Picker,et al.  CD4+ T‐cell depletion in HIV infection: mechanisms of immunological failure , 2013, Immunological reviews.

[24]  Rachael Hughes,et al.  Long-term immunologic response to antiretroviral therapy in low-income countries: a collaborative analysis of prospective studies , 2008, AIDS.

[25]  D. Weiner,et al.  Monkeying around with HIV vaccines: using rhesus macaques to define 'gatekeepers' for clinical trials , 2009, Nature Reviews Immunology.

[26]  William J. Kaiser,et al.  Divergent Host Responses during Primary Simian Immunodeficiency Virus SIVsm Infection of Natural Sooty Mangabey and Nonnatural Rhesus Macaque Hosts , 2005, Journal of Virology.

[27]  K. Beaumont,et al.  IL-Converting Enzyme/Caspase-1 Inhibitor VX-765 Blocks the Hypersensitive Response to an Inflammatory Stimulus in Monocytes from Familial Cold Autoinflammatory Syndrome Patients , 2005, The Journal of Immunology.

[28]  A. Perelson,et al.  Dynamics of HIV infection of CD4+ T cells. , 1993, Mathematical biosciences.

[29]  Xin Geng,et al.  Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection , 2013, Nature.

[30]  A. Fauci,et al.  Immunopathogenic mechanisms in human immunodeficiency virus (HIV) infections. , 1991, Annals of the New York Academy of Sciences.

[31]  M. Harding,et al.  ICE/Caspase-1 inhibitors as novel anti-inflammatory drugs , 2001, Expert opinion on investigational drugs.

[32]  L. Moulton,et al.  Behavioral Impact, Acceptability, and HIV Incidence Among Homosexual Men With Access to Postexposure Chemoprophylaxis for HIV , 2004, Journal of acquired immune deficiency syndromes.

[33]  A. Haase,et al.  Critical role of CD4 T cells in maintaining lymphoid tissue structure for immune cell homeostasis and reconstitution. , 2012, Blood.

[34]  M. Schechter,et al.  CD4+ blood lymphocytes are rapidly killed in vitro by contact with autologous human immunodeficiency virus-infected cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Alan S Perelson,et al.  Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues , 2014, Proceedings of the National Academy of Sciences.

[36]  Alan S. Perelson,et al.  Modeling Latently Infected Cell Activation: Viral and Latent Reservoir Persistence, and Viral Blips in HIV-infected Patients on Potent Therapy , 2009, PLoS Comput. Biol..

[37]  R. Hengel,et al.  Markers of lymphocyte homing distinguish CD4 T cell subsets that turn over in response to HIV-1 infection in humans. , 1999, Journal of immunology.

[38]  A. Vezzani,et al.  ICE/caspase 1 inhibitors and IL-1beta receptor antagonists as potential therapeutics in epilepsy. , 2010, Current opinion in investigational drugs.

[39]  Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. , 1981 .

[40]  Ashley T. Haase,et al.  Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS , 1993, Nature.

[41]  Evan Wood,et al.  Impact of HAART and injection drug use on life expectancy of two HIV-positive cohorts in British Columbia , 2006, AIDS.

[42]  J. Petravic,et al.  Limited CD4+ T cell proliferation leads to preservation of CD4+ T cell counts in SIV-infected sooty mangabeys , 2010, Proceedings of the Royal Society B: Biological Sciences.

[43]  Ross J. Harris,et al.  Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies , 2008, The Lancet.

[44]  R. Siliciano,et al.  Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection , 1997, Nature.

[45]  C. Sabin,et al.  Laboratory control values for CD4 and CD8 T lymphocytes. Implications for HIV‐1 diagnosis , 1992, Clinical and experimental immunology.

[46]  Richard H Middleton,et al.  Modeling the three stages in HIV infection. , 2013, Journal of theoretical biology.

[47]  J. Bijlsma,et al.  Interleukin-7-aggravated joint inflammation and tissue destruction in collagen-induced arthritis is associated with T-cell and B-cell activation , 2012, Arthritis Research & Therapy.

[48]  G. Pantaleo,et al.  Long-term kinetics of T cell production in HIV-infected subjects treated with highly active antiretroviral therapy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[49]  A. Fauci,et al.  The immunopathogenesis of human immunodeficiency virus infection. , 1993, The New England journal of medicine.

[50]  T. Sakaeda,et al.  Pharmacogenetics of drug transporters and its impact on the pharmacotherapy. , 2004, Current topics in medicinal chemistry.

[51]  A S Perelson,et al.  Rapid turnover of T lymphocytes in SIV-infected rhesus macaques. , 1998, Science.

[52]  Martin Meier-Schellersheim,et al.  CD4 T Cell Depletion Is Linked Directly to Immune Activation in the Pathogenesis of HIV-1 and HIV-2 but Only Indirectly to the Viral Load1 , 2002, The Journal of Immunology.

[53]  J. Schiffer,et al.  The Majority of CD4+ T-Cell Depletion during Acute Simian-Human Immunodeficiency Virus SHIV89.6P Infection Occurs in Uninfected Cells , 2014, Journal of Virology.

[54]  F. Sallusto,et al.  Cytokine-driven Proliferation and Differentiation of Human Naive, Central Memory, and Effector Memory CD4+ T Cells , 2001, The Journal of experimental medicine.

[55]  Mark Coles,et al.  IL-7-producing stromal cells are critical for lymph node remodeling. , 2012, Blood.

[56]  Time Scales of CD4+ T Cell Depletion in HIV Infection , 2007, PLoS medicine.

[57]  Alan S. Perelson,et al.  Increased Turnover of T Lymphocytes in HIV-1 Infection and Its Reduction by Antiretroviral Therapy , 2001, The Journal of experimental medicine.

[58]  Z. Grossman,et al.  The Journal of Experimental Medicine , 2000 .

[59]  D. Kirschner,et al.  Model of HIV-1 disease progression based on virus-induced lymph node homing and homing-induced apoptosis of CD4+ lymphocytes. , 2000, Journal of acquired immune deficiency syndromes.

[60]  D. Hazuda,et al.  The kinetics of interleukin 1 secretion from activated monocytes. Differences between interleukin 1 alpha and interleukin 1 beta. , 1988, The Journal of biological chemistry.

[61]  Alan S. Perelson,et al.  In vivo dynamics of T cell activation, proliferation, and death in HIV-1 infection: Why are CD4+ but not CD8+ T cells depleted? , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[62]  Libin Rong,et al.  Modeling HIV persistence, the latent reservoir, and viral blips. , 2009, Journal of theoretical biology.

[63]  Wolfgang Löscher,et al.  Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases , 2005, Progress in Neurobiology.

[64]  V. Quagliarello The Acquired Immunodeficiency Syndrome: current status. , 1982, The Yale journal of biology and medicine.

[65]  Rustom Antia,et al.  Understanding the Slow Depletion of Memory CD4+ T Cells in HIV Infection , 2007, PLoS medicine.

[66]  H. Masur,et al.  An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction. , 1981, The New England journal of medicine.

[67]  A. Haase,et al.  Population biology of HIV-1 infection: viral and CD4+ T cell demographics and dynamics in lymphatic tissues. , 1999, Annual review of immunology.

[68]  Robert Tibshirani,et al.  Bootstrap Methods for Standard Errors, Confidence Intervals, and Other Measures of Statistical Accuracy , 1986 .

[69]  Joan S. Chmiel,et al.  Acquired immunodeficiency syndrome (AIDS)-free time after human immunodeficiency virus type 1 (HIV-1) seroconversion in homosexual men. Multicenter AIDS Cohort Study Group. , 1989, American journal of epidemiology.

[70]  R H Lyles,et al.  Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. Multicenter AIDS Cohort Study. , 2000, The Journal of infectious diseases.

[71]  J. Tschopp,et al.  Caspase-1 Activation of Lipid Metabolic Pathways in Response to Bacterial Pore-Forming Toxins Promotes Cell Survival , 2006, Cell.

[72]  R. Gallo,et al.  Detection of lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[73]  A. Haase,et al.  Lymphoid tissue structure and HIV-1 infection: life or death for T cells. , 2012, Trends in immunology.

[74]  J. McCune,et al.  The dynamics of CD4+ T-cell depletion in HIV disease , 2001, Nature.

[75]  Kholoud Porter,et al.  Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy , 2014, AIDS.